文献速递乳腺癌

Ⅱ-Ⅲ期乳腺癌局部区域复发时同步远处转移风险(AFT-01)

Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01).
PubMed 文献 · J Clin Oncol · 2018-01-31

该研究基于美国国家癌症数据库2006—2007年Ⅱ-Ⅲ期乳腺癌分层随机样本,分析5年内局部区域复发患者中同步远处转移的比例及相关因素。结果显示局部区域复发者中27%存在同步远处转移,淋巴结复发者比例最高达35%;54%的患者在局部区域复发后30天内接受了全身分期影像检查。

要点

  • 局部区域复发患者中27%同期发现远处转移,淋巴结复发者达35%
  • 初诊分期、复发类型和保险状态与同步远处转移相关
  • 结果支持局部区域复发时行全身影像分期,尤其淋巴结或胸壁复发者

核心结论

  • 局部区域复发时同步远处转移并不少见,支持现行全身影像分期推荐,尤其淋巴结或胸壁复发患者。

研究设计与样本

  • 从美国国家癌症数据库按分期分层随机抽取2006—2007年Ⅱ-Ⅲ期乳腺癌患者11046例参与Commission on Cancer专项研究。
  • 通过病历记录提取影像与复发数据,识别诊断后5年内发生局部区域复发者,并判定局部区域复发30天内的同步远处转移。
  • 采用多因素logistic回归分析与同步远处转移相关的因素。

主要发现

  • 4%的患者发生局部区域复发(n=445),其中27%(n=120)发现同步远处转移。
  • 初诊分期(P=.03)、局部区域复发类型(P=.01)和保险状态(P=.03)与同步远处转移相关。
  • 同步远处转移比例在淋巴结复发(35%)、乳房切除术后胸壁复发(30%)和乳腺内复发(15%)中依次不同。
  • 54%的患者在局部区域复发后30天内接受了全身分期影像检查。

关键数值与推荐

  • 同步远处转移定义为局部区域复发30天内发现的远处转移。
  • 局部区域复发类型中同步远处转移比例:淋巴结复发35%、乳房切除术后胸壁复发30%、乳腺内复发15%。

临床怎么用

  • 对Ⅱ-Ⅲ期乳腺癌局部区域复发患者应考虑全身分期影像,尤其淋巴结或胸壁复发者。
  • 早期识别远处转移可避免对已存在转移者给予不太可能延长生存的局部区域治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose National Comprehensive Cancer Network guidelines recommend systemic staging imaging at the time of locoregional breast cancer recurrence. Limited data support this recommendation. We determined the rate of synchronous distant recurrence at the time of locoregional recurrence in high-risk patients and identified clinical factors associated with an increased risk of synchronous metastases. Methods A stage-stratified random sample of 11,046 patients with stage II to III breast cancer in 2006 to 2007 was selected from the National Cancer Database for participation in a Commission on Cancer special study. From medical record abstraction of imaging and recurrence data, we identified patients who experienced locoregional recurrence within 5 years of diagnosis. Synchronous distant metastases (within 30 days of locoregional recurrence) were determined. We used multivariable logistic regression to identify factors associated with synchronous metastases. Results Four percent experienced locoregional recurrence (n = 445). Synchronous distant metastases were identified in 27% (n = 120). Initial presenting stage ( P = .03), locoregional recurrence type ( P = .01), and insurance status ( P = .03) were associated with synchronous distant metastases. The proportion of synchronous metastases was highest for women with lymph node (35%), postmastectomy chest wall (30%), and in-breast (15%) recurrence; 54% received systemic staging imaging within 30 days of a locoregional recurrence. Conclusion These findings support current recommendations for systemic imaging in the setting of locoregional recurrence, particularly for patients with lymph node or chest wall recurrences. Because most patients with isolated locoregional recurrence will be recommended locoregional treatment, early identification of distant metastases through routine systemic imaging may spare them treatments unlikely to extend their survival.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Neuman HB, Schumacher JR, Francescatti AB, et al. Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01). J Clin Oncol. 2018. PMID: 29384721. doi:10.1200/JCO.2017.75.5389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。